At Estique Clinic, our expert dermatologist, Dr
nurses stepping off the picket lines amid mediation02:07 | July 14, 2026 Music choices reshape your brain, research reveals01:38 | July 14, 2026 Semaglutide associated with blindness risk, study suggests Description July 4, 2024 A new study suggests there is an association between taking the active drug in Ozempic and Wegovy, and the development of condition that causes blindness
It might be frustrating and expensive, but the risk of injecting a compromised medication isnt worth it
As mentioned above, obesity is associated with heavier menstrual bleeding, so weight loss, whether it is fueled by Ozempic use or not, may actually lead to lighter periods
Both Semaglutide and Tirzepatide use unique mechanisms that not only aid in weight loss but also do it more effectively and safely compared to many traditional weight loss methods
They are not FDA-approved for treating diabetes or obesity and are not substitutes for prescription medications or evidence-based lifestyle interventions for metabolic health